The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 05, 2006

Filed:

Jul. 13, 2004
Applicants:

Rajashree Joshi-hangal, Union City, CA (US);

Xichen Zhang, Thousand Oaks, CA (US);

Stephanie Gong, Pleasanton, CA (US);

Sanjeev Redkar, Union City, CA (US);

Ashok Y. Gore, San Ramon, CA (US);

Inventors:

Rajashree Joshi-Hangal, Union City, CA (US);

Xichen Zhang, Thousand Oaks, CA (US);

Stephanie Gong, Pleasanton, CA (US);

Sanjeev Redkar, Union City, CA (US);

Ashok Y. Gore, San Ramon, CA (US);

Assignee:

SuperGen, Inc., Dublin, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/04 (2006.01); A61K 31/70 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
Abstract

Pharmaceutical formulations, kits and vessels are provided for delivering decitabine to a patient suffering from a disease in need of treatment with decitabine. The pharmaceutical formulation comprises decitabine solvated in a non-aqueous solvent that comprises glycerin, propylene glycol, polyethylene glycol, or combinations. Such formulations are more chemically stable than conventional liquid formulations of decitabine containing more than 40% water in volume. The pharmaceutical formulations can be used for any disease that is sensitive to the treatment with decitabine, such as hematological disorders and cancer.


Find Patent Forward Citations

Loading…